Last reviewed · How we verify

NCT05602922

Liu-Zi-Jue Exercise Combined With Conventional Rehabilitation Treat Dysphagia in Post-stroke

Status unknown NA Last updated 2 November 2022
What this trial tests

NA trial testing Liu-Zi-Jue Exercise in Stroke in 60 participants. Status unknown.

Timeline
1 April 2022
Primary endpoint
30 December 2023
30 December 2023

Quick facts

Lead sponsorThe Third Affiliated hospital of Zhejiang Chinese Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date1 April 2022
Primary completion30 December 2023
Estimated completion30 December 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The Third Affiliated hospital of Zhejiang Chinese Medical University

Who can join

Adults 30 to 85, any sex, with Stroke or Dysphagia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, a prospective, randomized controlled method was adopted, with patients with post-stroke dysphagia as the main research objects, applying "Liu-Zi-Jue" to the patients for rehabilitation intervention, and to explore the effect of "Liu-Zi-Jue" on the swallowing function of patients with post-stroke dysphagia. In order to provide a safe and effective TCM treatment plan for patients with dysphagia after stroke, reduce the disability rate after stroke and improve the quality of life of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other The Third Affiliated hospital of Zhejiang Chinese Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05602922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing